首页|酪氨酸激酶介导葡萄糖-6-磷酸脱氢酶核定位靶向调控原癌基因蛋白下游调节基因促进膀胱癌细胞生长及转移的作用及机制

酪氨酸激酶介导葡萄糖-6-磷酸脱氢酶核定位靶向调控原癌基因蛋白下游调节基因促进膀胱癌细胞生长及转移的作用及机制

扫码查看
目的 探究葡萄糖-6-磷酸脱氢酶(G6PD)和酪氨酸激酶(SRC)在膀胱癌发生发展中的作用及其机制.方法 收集2012年12月至2018年12月温州医科大学附属第二医院的30例膀胱癌患者膀胱肿瘤切除术后收集的癌组织和癌旁组织,应用蛋白免疫印记法检测G6PD和SRC在膀胱癌组织和癌旁组织中的表达水平.同时,通过干扰G6PD和SRC的表达水平,检测T24和J82细胞的增殖、凋亡和迁移能力.最后,通过干扰SRC联合G6PD过表达证实其促进膀胱癌进展的功能,两组比较应用两独立样本t检验,多组比较采用方差分析.结果 肿瘤组中G6PD的表达高于对照组(1.07倍比0.58倍,t=2.80,P<0.05),肿瘤组中SRC的表达高于对照组(0.96倍比0.54倍,=3.25,P<0.01).干扰SRC和G6PD后,SRC干扰组的S期的细胞比例高于对照组(26.47 比32.75,t=2.87,P<0.05),G6PD干扰组的S期的细胞比例高于对照组(26.47比32.26,t=2.85,P<0.05).SRC干扰组的细胞凋亡率高于对照组(6.66比41.81,t=69.95,P<0.01),G6PD干扰组的细胞凋亡率高于对照组(6.66比43.61,t=48.55,P<0.01).SRC敲低+G6PD过表达组致癌基因下游调控蛋白(NDRG1)表达水平高于G6PD过表达组(0.76比0.48,t=8.55,P<0.01),SRC敲低+G6PD过表达组丝氨酸/苏氨酸蛋白激酶(p-Akt)表达水平低于G6PD过表达组(0.34比0.47,t=4.72,P<0.01).结论 SRC通过调控G6PD核易位调控NDRG1的表达水平,在膀胱癌的进展中发挥促进作用.
A novel mechanism of Sarcoma tyrosine kinase-mediated Glucose-6-phosphatedehydrogenase nuclear localization targeting and regulating N-Myc downstream regulated gene 1 to promote the growth and metastasis of bladder cancer cells
Objective To explore the function and mechanism of Glucose-6-phosphate dehydrogen-ase(G6PD)and Sarcoma tyrosine kinase(Src)in the development of bladder cancer.Methods Collect cancer tissues and adjacent tissues from 30 bladder cancer patients who underwent bladder tumor resection at the Second Affiliated Hospital of Wenzhou Medical University from December 2012 to December 2018.We detected the expression of G6PD and SRC in cancer tissues and paracancerous tissues of bladder cancer patients.Meanwhile,we detected the cell proliferation,apoptosis and migration abilities in T24 and J82 cells through interfering the expression levels of G6PD and SRC,respectively.Finally,the function of pro-moting bladder cancer progression was confirmed by interfering with SRC combined with G6PD overexpres-sion.Results The expression levels of G6PD in tumor group were higher than those in control group(1.07 vs.0.58,t=2.80,P<0.05).The expression levels of SRC in tumor group were higher than those in control group(0.96 vs.0.54,t=3.25,P<0.01).After interfering with SRC and G6PD,the proportion of cells in the S phase was higher in the SRC interference group compared to the control group(26.47 vs.32.75,t=2.87,P<0.05),and also higher in the G6PD interference group compared to the control group(26.47 vs.32.26,t=2.85,P<0.05).The apoptosis rate of cells was higher in both the SRC interference group(6.66 vs.41.81,t=69.95,P<0.01)and G6PD interference group(6.66 vs.43.61,t=48.55,P<0.01)compared to the control group.The expression of N-Myc downstream regulated gene 1(NDRG1)was higher in the SRC knockdown+G6PD overexpression group than in the G6PD overexpression alone group(0.76 vs.0.48,t=8.55,P<0.01),while the expression of p-serine/threonine protein kinase(p-Akt)was lower in SRC knockdown+G6PD overexpression group than in G6PD overexpression alone grouo(0.34 vs.0.47,t=4.72,P<0.01).Conclusion SRC regulated the expression level of NDRG1 by regulating G6PD nuclear translocation and finally played a role in promoting the progression of bladder cancer.

Glucose-6-phosphate dehydrogenaseSarcoma tyrosine kinaseBladder cancerPentose phosphate pathway

宫剑、黄象维、张大贵、虞海峰、李宝青

展开 >

温州医科大学附属第二医院临床检验中心,温州 325027

温州医科大学附属第二医院病理科,温州 325027

温州医科大学附属第二医院泌尿外科,温州 325027

葡萄糖-6-磷酸脱氢酶 酪氨酸激酶 膀胱癌 磷酸戊糖途径

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(12)